PAVmed Inc. Selling and Marketing Expense
PAVmed Inc. (PAVM) reported Selling and Marketing Expense of $215.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-13
- PAVmed Inc. selling and marketing expense for the quarter ending 2026-06-30 was $215.00K, a 2.27% decline year-over-year.
- PAVmed Inc. selling and marketing expense for the quarter ending 2026-03-31 was $216.00K, a 12.55% decline year-over-year.
- PAVmed Inc. selling and marketing expense for the quarter ending 2025-12-31 was $249.00K, a 60.65% increase year-over-year.
- PAVmed Inc. selling and marketing expense for the quarter ending 2025-09-30 was $201.00K, a 93.12% decline year-over-year.
- PAVmed Inc. selling and marketing expense for fiscal 2025 was $917.00K, a 92.11% decline from fiscal 2024.
- PAVmed Inc. selling and marketing expense for fiscal 2024 was $11.63M, a 33.87% decline from fiscal 2023.
- PAVmed Inc. selling and marketing expense for fiscal 2023 was $17.58M, a 8.98% decline from fiscal 2022.
- PAVmed Inc. selling and marketing expense for fiscal 2022 was $19.32M, a 117.18% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $215.00K 10-Q · filed 2026-08-13 | $430.00K 10-Q · filed 2026-08-13 | $680.00K derived: sum of 3 quarters · filed 2026-08-13 | $881.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $216.00K 10-Q · filed 2026-05-14 | $465.00K derived: sum of 2 quarters · filed 2026-05-14 | $666.00K derived: sum of 3 quarters · filed 2026-05-14 | $886.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $450.00K derived: sum of 2 quarters · filed 2026-03-27 | $670.00K derived: sum of 3 quarters · filed 2026-08-13 | $917.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $201.00K 10-Q · filed 2025-11-12 | $421.00K derived: sum of 2 quarters · filed 2026-08-13 | $668.00K 10-Q · filed 2025-11-12 | $823.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $220.00K 10-Q · filed 2026-08-13 | $467.00K 10-Q · filed 2026-08-13 | $622.00K derived: sum of 3 quarters · filed 2026-08-13 | $3.54M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $247.00K 10-Q · filed 2026-05-14 | $402.00K derived: sum of 2 quarters · filed 2026-05-14 | $3.32M derived: sum of 3 quarters · filed 2026-05-14 | $7.56M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $3.08M derived: sum of 2 quarters · filed 2026-03-27 | $7.32M derived: sum of 3 quarters · filed 2026-03-27 | $11.63M 10-K · filed 2026-03-27 |
| 2024-09-30 | $2.92M 10-Q · filed 2025-11-12 | $7.16M derived: sum of 2 quarters · filed 2025-11-12 | $11.47M 10-Q · filed 2025-11-12 | $16.16M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $4.24M 10-Q · filed 2025-08-14 | $8.55M 10-Q · filed 2025-08-14 | $13.24M derived: sum of 3 quarters · filed 2025-08-14 | $17.26M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $4.31M 10-Q · filed 2025-05-15 | $9.00M derived: sum of 2 quarters · filed 2025-05-15 | $13.02M derived: sum of 3 quarters · filed 2025-05-15 | $17.36M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $8.71M derived: sum of 2 quarters · filed 2025-03-24 | $13.04M derived: sum of 3 quarters · filed 2025-03-24 | $17.58M 10-K · filed 2025-03-24 |
| 2023-09-30 | $4.02M 10-Q · filed 2024-11-14 | $8.36M derived: sum of 2 quarters · filed 2024-11-14 | $12.89M 10-Q · filed 2024-11-14 | $18.65M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $4.34M 10-Q · filed 2024-08-12 | $8.88M 10-Q · filed 2024-08-12 | $14.64M derived: sum of 3 quarters · filed 2024-08-12 | $19.37M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $4.54M 10-Q · filed 2024-05-13 | $10.30M derived: sum of 2 quarters · filed 2024-05-13 | $15.03M derived: sum of 3 quarters · filed 2024-05-13 | $19.93M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $10.49M derived: sum of 2 quarters · filed 2024-03-25 | $15.39M derived: sum of 3 quarters · filed 2024-03-25 | $19.32M 10-K · filed 2024-03-25 |
| 2022-09-30 | $4.74M 10-Q · filed 2023-11-13 | $9.63M derived: sum of 2 quarters · filed 2023-11-13 | $13.56M 10-Q · filed 2023-11-13 | $16.90M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $4.90M 10-Q · filed 2023-08-14 | $8.82M 10-Q · filed 2023-08-14 | $12.16M derived: sum of 3 quarters · filed 2023-08-14 | $14.46M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $3.92M 10-Q · filed 2023-05-15 | $7.26M derived: sum of 2 quarters · filed 2023-05-15 | $9.56M derived: sum of 3 quarters · filed 2023-05-15 | $11.43M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $5.63M derived: sum of 2 quarters · filed 2023-03-14 | $7.51M derived: sum of 3 quarters · filed 2023-03-14 | $8.89M 10-K · filed 2023-03-14 |
| 2021-09-30 | $2.29M 10-Q · filed 2022-11-14 | $4.17M derived: sum of 2 quarters · filed 2022-11-14 | $5.55M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.88M 10-Q · filed 2022-08-15 | $3.26M 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $1.39M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $2.79M 10-K · filed 2022-04-06 | |||
| 2020-03-31 | $385.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |